As of August 1, 2026, all imported generic drugs to the United States will remain subject to a zero percent tariff for an additional 2 years. After that, this tariff will increase to 100 percent for 1 year and then to 200 percent. This action is intended to bring generic drug production back to the United States, and companies that do not build factories and facilities inside the United States during the specified period will be subject to this tariff penalty. The purpose of this policy is to protect the people of the United States. The policy regarding drugs with patents, brand-name drugs, and highly successful innovative drugs will remain unchanged. At present, drug production facilities across the United States are being constructed at a level that has never been seen before. Thank you for your attention to this matter!

President Donald J. Trump